Health Catalyst, Inc.

Equities

HCAT

US42225T1079

Software

Market Closed - Nasdaq 16:00:00 2024-05-10 EDT 5-day change 1st Jan Change
6.41 USD -3.90% Intraday chart for Health Catalyst, Inc. -1.08% -30.78%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Wells Fargo Adjusts Price Target on Health Catalyst to $13 From $14, Keeps Overweight Rating MT
Health Catalyst Seeks M&A CI
Health Catalyst, Inc. Provides Revenue Guidance for the Second Quarter and Full Year of 2024 CI
Transcript : Health Catalyst, Inc., Q1 2024 Earnings Call, May 09, 2024
Earnings Flash (HCAT) HEALTH CATALYST Posts Q1 Revenue $74.7M, vs. Street Est of $74.8M MT
Earnings Flash (HCAT) HEALTH CATALYST Posts Q1 EPS $0.05, vs. Street Est of $0.03 MT
Health Catalyst, Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024 CI
North American Morning Briefing : Stock Futures -2- DJ
KeyBanc Downgrades Health Catalyst to Sector Weight From Overweight on Potential Risks to Hospital End Markets MT
North American Morning Briefing : Traders Await -2- DJ
Transcript : Health Catalyst, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 10:15 AM
Health Catalyst Shares Rise After CEO Stock Purchase MT
Transcript : Health Catalyst, Inc. - Special Call
KeyBanc Cuts Price Target on Health Catalyst to $10 From $12, Keeps Overweight Rating MT
Evercore ISI Adjusts Price Target on Health Catalyst to $10 From $11, Maintains Outperform Rating MT
Canaccord Genuity Trims Price Target on Health Catalyst to $11 From $12, Maintains Buy Rating MT
Transcript : Health Catalyst, Inc., Q4 2023 Earnings Call, Feb 22, 2024
Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 EPS $0.02, vs. Street Est of $-0.01 MT
Health Catalyst, Inc. Announces CFO Changes, Effective March 1, 2024 CI
Health Catalyst, Inc. Announces Board Changes, Effective March 1, 2024 CI
Health Catalyst, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Earnings Flash (HCAT) HEALTH CATALYST Posts Q4 Revenue $75.1M, vs. Street Est of $73.6M MT
Health Catalyst, Inc. Provides Revenue Guidance for the First Quarter and Full Year of 2024 CI
Health Catalyst, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
North American Morning Briefing : Cautious Start -2- DJ
Chart Health Catalyst, Inc.
More charts
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company’s solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
6.41 USD
Average target price
11.93 USD
Spread / Average Target
+86.09%
Consensus
1st Jan change Capi.
-30.78% 378M
-19.16% 216B
-10.77% 65.35B
-3.97% 56.04B
-10.56% 46.58B
-1.99% 39.8B
-7.07% 33.99B
-9.54% 28.66B
+116.89% 28.44B
+2.88% 21.55B
Application Software
  1. Stock Market
  2. Equities
  3. HCAT Stock
  4. News Health Catalyst, Inc.
  5. Health Catalyst : Forms Partnership With Oklahoma Heart Hospital to Improve Analytics
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW